The BACKBEAT Global Pivotal Trial, which Orchestra BioMed is actively enrolling as part of a strategic collaboration with Medtronic (NYSE: MDT), targets a similar patient population as MODERATO II ...

Leonardo da Vinci was sketching the human body long before modern medicine even existed. One of his more curious drawings ...

Activity of a gene called RUNX1 may be a biological marker of the processes that can lead to right heart failure in PAH, a ...

Bonn, 22 April 2026 – Until now, there have been few therapeutic options for children with severely reduced heart pump function. Recently, surgical ...

Researchers at the University Hospital Bonn (UKB) and the University of Bonn investigated the underlying biological mechanisms of this approach. Using a mouse model, they demonstrated that pressure ...

Management plans to file for regulatory approval of "Tresmi" for PAH and ILD this year, with commercial launch targeted for next year. Tyvaso DPI platform enhancement -- Introduction of 80-microgram ...

Bonn, 22 April 2026 – Until now, there have been few therapeutic options for children with severely reduced heart pump ...

Until now, there have been few therapeutic options for children with severely reduced heart pump function. Recently, surgical ...

The cardiovascular system primarily delivers oxygen and nutrients to tissues. Oxygen delivery depends on cardiac output and arterial oxygen content. While left ventricular function is often emphasized ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., April 20, 2026--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that 11 new data presentations across ...

Introduction Reduced exercise performance is common in patients with repaired tetralogy of Fallot (rToF) and relates to ...